Changes in kallikrein and kinin levels could be an alternative explanation for the observed progression of hypertension and renal damage as kinins exhibit vasodilatory effects and may afford renoprotection through AT2 and B2 receptors. This evidence concerns the gene KLK4 and hypertensive disorder.